| Nome |
# |
|
Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy, file e3835319-cc64-15e8-e053-a505fe0a3de9
|
205
|
|
Subcutaneous implantable cardioverter defibrillator in cardiomyopathies and channelopathies, file e383531e-b925-15e8-e053-a505fe0a3de9
|
204
|
|
Distinguishing hypertension from hypertrophic cardiomyopathy as a cause of left ventricular hypertrophy, file e3835312-4d62-15e8-e053-a505fe0a3de9
|
137
|
|
The natural history of hypertrophic cardiomyopathy, file e383532c-27ba-15e8-e053-a505fe0a3de9
|
118
|
|
A next-generation sequencing approach to identify gene mutations in early-and late-onset hypertrophic cardiomyopathy patients of an Italian cohort, file e3835315-9c40-15e8-e053-a505fe0a3de9
|
100
|
|
Risk stratification in hypertrophic cardiomyopathy. Insights from genetic analysis and cardiopulmonary exercise testing, file e3835326-4e26-15e8-e053-a505fe0a3de9
|
93
|
|
Insights from cardiopulmonary exercise testing in pediatric patients with hypertrophic cardiomyopathy, file e383532c-2ab9-15e8-e053-a505fe0a3de9
|
85
|
|
Coronavirus disease 2019 in patients with cardiovascular disease. clinical features and implications on cardiac biomarkers assessment, file e383532c-d3d9-15e8-e053-a505fe0a3de9
|
75
|
|
Long-term management of Takotsubo syndrome: a not-so-benign condition, file e383532c-d445-15e8-e053-a505fe0a3de9
|
61
|
|
Sacubitril/Valsartan as a therapeutic tool across the range of Heart Failure phenotypes and ejection fraction spectrum, file e383532c-e5de-15e8-e053-a505fe0a3de9
|
53
|
|
A Novel Nonsense Pathogenic TTN Variant Identified in a Patient with Severe Dilated Cardiomyopathy, file 0c441c11-4980-4c42-8c77-25ce77c0e620
|
52
|
|
Yield of bone scintigraphy screening for transthyretin-related cardiac amyloidosis in different conditions. Methodological issues and clinical implications, file e383532d-13b1-15e8-e053-a505fe0a3de9
|
52
|
|
Home infusion program with enzyme replacement therapy for Fabry disease: The experience of a large Italian collaborative group., file e3835329-606f-15e8-e053-a505fe0a3de9
|
50
|
|
Left ventricular remodeling in hypertrophic cardiomyopathy: an overview of current knowledge, file e383532b-f50b-15e8-e053-a505fe0a3de9
|
49
|
|
Current patterns of beta-blocker prescription in cardiac amyloidosis. an Italian nationwide survey, file e383532d-5556-15e8-e053-a505fe0a3de9
|
49
|
|
Takotsubo syndrome. hyperthyroidism, pheochromocytoma, or both? A case report, file e383532d-5559-15e8-e053-a505fe0a3de9
|
47
|
|
Incidence, determinants and prognostic relevance of dyspnea at admission in patients with Takotsubo syndrome. results from the international multicenter GEIST registry., file e383532b-cdda-15e8-e053-a505fe0a3de9
|
44
|
|
Novel Imaging and Genetic Risk Markers in Takotsubo Syndrome, file e383532c-aa7c-15e8-e053-a505fe0a3de9
|
44
|
|
Calcium Channel Blockers and Hypertension., file e3835312-7135-15e8-e053-a505fe0a3de9
|
30
|
|
IGF-1 and atherothrombosis: relevance to pathophysiology and therapy, file e3835311-f4a2-15e8-e053-a505fe0a3de9
|
28
|
|
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy. a multicentre network study, file 139f9ea7-5963-457e-b2d4-89f3465aa39a
|
27
|
|
Risk stratification in transthyretin-related cardiac amyloidosis, file 02d8b8b9-c8b8-4a09-8e0e-10bac949d1c2
|
23
|
|
Risk of Sudden Death and Outcome in Patients With Hypertrophic Cardiomyopathy With Benign Presentation and Without Risk Factors, file e3835312-5f81-15e8-e053-a505fe0a3de9
|
19
|
|
Old and new therapeutic solutions in the treatment of hypertrophic cardiomyopathy, file 5989fc17-b639-454a-8870-c6c42f503d18
|
14
|
|
Long QTc in hypertrophic cardiomyopathy. A consequence of structural myocardial damage or a distinct genetic disease?, file 0a0910e7-c6a2-4b56-ba6b-2c9ec171e183
|
13
|
|
Current patterns of beta-blocker prescription in cardiac amyloidosis. an Italian nationwide survey, file 870ad840-c84a-4f7a-9794-02a6f29a5b16
|
12
|
|
Clinical translation of genetic testing in TTR Amyloidosis. genotype-phenotype correlations, management of asymptomatic carriers and familial screening, file 21ab3790-44c5-4083-8d2f-30dc4989e4d4
|
11
|
|
Oxidative stress and cardiovascular disease, file e3835311-963c-15e8-e053-a505fe0a3de9
|
11
|
|
Erythropoietin and the heart: facts and perspectives., file e3835311-b84c-15e8-e053-a505fe0a3de9
|
10
|
|
New oral anticoagulants in non-valvular atrial fibrillation., file e3835311-caec-15e8-e053-a505fe0a3de9
|
10
|
|
QT spatial dispersion and sudden cardiac death in hypertrophic cardiomyopathy. time for reappraisal., file e383531a-559e-15e8-e053-a505fe0a3de9
|
10
|
|
The Swiss cheese model in takotsubo syndrome, file 5ad1d966-a1ce-4911-9e96-d94999a39aa4
|
9
|
|
Exploring the influence of takotsubo syndrome on oncologic patients' mortality, file bf25acc4-1c17-4560-9b0a-94b21cb56656
|
9
|
|
Role of Arterial Hypertension and Hypertension-Mediated Organ Damage in Cardiotoxicity of Anticancer Therapies, file cdd8468a-fb1e-4896-981b-60c9d5616708
|
9
|
|
Long-Term Tolerability and Efficacy of the Fixed Combination of Manidipine and Delapril in Patients with Essential Hypertension, file e3835312-482d-15e8-e053-a505fe0a3de9
|
9
|
|
Recombinant human insulin-like growth factor-1: a new cardiovascolar disease treatment option?, file e383531e-7c44-15e8-e053-a505fe0a3de9
|
9
|
|
Clinical course of hypertrophic cardiomyopathy patients implanted with a transvenous or a subcutaneous defibrillator, file faa469d6-83da-4409-92ab-4dca920669fa
|
9
|
|
CHA2DS2-VASc score in patients with COVID-19 pneumonia and its relationship with biomarkers of thrombosis, inflammation and myocardial injury, file 746255c5-9eb7-4207-ad9d-3f8fd6b0cd76
|
8
|
|
Cardioembolic stroke in cardiac amyloidosis. the real challenge lies beyond heart rhythm, file d8cb0400-9fbb-422f-8a3a-c965aeb0a8e0
|
8
|
|
Genetic susceptibility to cerebrovascular accidents., file e3835311-b55a-15e8-e053-a505fe0a3de9
|
8
|
|
Congenital Accessory Mitral Valve Tissue Anomaly in a Patient with Genetically Confirmed Hypertrophic Cardiomyopathy, file e3835311-ca0a-15e8-e053-a505fe0a3de9
|
8
|
|
Spatial QT dispersion predicts non-sustained ventricula tachycardia and correlates with a confined systo-diastolic dysfunction un hypertrophic cardiomyopathy, file e3835311-e9b7-15e8-e053-a505fe0a3de9
|
8
|
|
Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease, file e3835312-5317-15e8-e053-a505fe0a3de9
|
8
|
|
Low QRS Voltages in Cardiac Amyloidosis. Clinical Correlates and Prognostic Value, file 57e28c81-8126-4919-b749-51a7e12588fa
|
7
|
|
Yield of bone scintigraphy screening for transthyretin-related cardiac amyloidosis in different conditions. Methodological issues and clinical implications, file 88224ebc-82b1-454f-b3ee-2d02eca8b9d9
|
7
|
|
Arterial thrombotic events and acute coronary syndromes with cancer drugs: Are growth factors the missed link? What both cardiologist and oncologist should know about novel angiogenesis inhibitors, file e3835311-735f-15e8-e053-a505fe0a3de9
|
7
|
|
Left ventricular remodeling in hypertrophic cardiomyopathy: an overview of current knowledge, file cbe2d721-5592-414d-860d-3e5b084c0f46
|
6
|
|
Simultaneous Takotsubo syndrome in two sisters, file e3835311-e62a-15e8-e053-a505fe0a3de9
|
6
|
|
Erythropoietin in cardiac disease: effective or harmful?, file e3835312-2fb6-15e8-e053-a505fe0a3de9
|
6
|
|
Substrates of scar-related ventricular arrhythmia in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study, file 6adb6e01-548c-4622-959d-03b6e901d7ac
|
5
|
|
High Risk for Sudden Death Identified by Electrocardiographic Loop Recording in a Patient With Hypertrophic Cardiomyopathy Without Major Risk Factors, file e3835312-186f-15e8-e053-a505fe0a3de9
|
5
|
|
Update on phase II studies of erythropoietin in acute myocardial infarction. Rationale and design of Exogenous erythroPoietin in Acute Myocardial Infarction: New outlook and dose association study (EPAMINONDAS), file e3835312-1b85-15e8-e053-a505fe0a3de9
|
5
|
|
An atypical clinical presentation of renovascular hypertension., file e3835312-2fc2-15e8-e053-a505fe0a3de9
|
5
|
|
Relation of delayed intrinsicoid deflection of the QRS complex to sudden cardiac death in patients with hypertrophic cardiomyopathy, file 63ec89e6-6c2a-4a4d-ac70-f59e9000aed0
|
4
|
|
Determinants of peak oxygen uptake in patients with hypertrophic cardiomyopathy: a single-center study, file e3835312-221d-15e8-e053-a505fe0a3de9
|
4
|
|
Prognostic implications of defibrillation threshold testing in patients with hypertrophic cardiomyopathy, file e3835316-04c4-15e8-e053-a505fe0a3de9
|
4
|
|
Favourable impact of statin use on diastolic blood pressure levels: analysis of a large database of 24-hour ambulatory blood pressure monitoring, file e3835317-dfc5-15e8-e053-a505fe0a3de9
|
4
|
|
Pulmonary hypertension and clinical correlates in hypertrophic cardiomyopathy, file e3835318-a00d-15e8-e053-a505fe0a3de9
|
4
|
|
Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy, file e383531b-9969-15e8-e053-a505fe0a3de9
|
4
|
|
Happy heart syndrome. frequency, characteristics, and outcome of takotsubo syndrome triggered by positive life events, file 21f1df3c-1914-47c5-92b4-5d465030d162
|
3
|
|
A contemporary update on cancer and takotsubo syndrome, file 748d3a64-26d0-4f65-af2d-27c0f2047baa
|
3
|
|
Impact of intra-Aortic balloon counterpulsation on all-cause mortality among patients with Takotsubo syndrome complicated by cardiogenic shock. Results from the German-Italian-Spanish (GEIST) registry, file 749de0bf-469c-4390-9b83-0c69bf0c0533
|
3
|
|
Independent association of ECG abnormalities with microalbuminuria and renal damage in hypertensive patients without overt cardiovascular disease: Data from Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study, file e3835311-e079-15e8-e053-a505fe0a3de9
|
3
|
|
Isoleucyl-tRNA synthetase levels modulate the penetrance of a homoplasmic m.4277T > C mitochondrial tRNA(Ile) mutation causing hypertrophic cardiomyopathy, file e3835311-f517-15e8-e053-a505fe0a3de9
|
3
|
|
Eligibility for the subcutaneous implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy, file e3835312-ccb6-15e8-e053-a505fe0a3de9
|
3
|
|
Long-Term Outcome of Acute Coronary Syndromes in Young Patients, file e383531b-7451-15e8-e053-a505fe0a3de9
|
3
|
|
Tortuosity, Recurrent Segments, and Bridging of the Epicardial Coronary Arteries in Patients With the Takotsubo Syndrome, file e383531b-7453-15e8-e053-a505fe0a3de9
|
3
|
|
Long-Term Left Ventricular Remodeling of Patients With Hypertrophic Cardiomyopathy, file e383531d-33bc-15e8-e053-a505fe0a3de9
|
3
|
|
Recombinant human insulin-like growth factor-1: a new cardiovascolar disease treatment option?, file e3835321-35c8-15e8-e053-a505fe0a3de9
|
3
|
|
Low sensitivity of bone scintigraphy in detecting Phe64Leu mutation-related transthyretin cardiac amyloidosis, file e3835327-0cec-15e8-e053-a505fe0a3de9
|
3
|
|
Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy. Role of age and heart failure phenotypes, file eccda262-9702-41bc-9fad-c8f579e42add
|
3
|
|
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population, file efeae4ec-a1b7-4ec4-8d3c-1d4ce36be62d
|
3
|
|
[Rationale and significance of the italian network for cardiac amyloidosis], file 0736fc40-3c57-4b49-8652-7f24ca1e9383
|
2
|
|
Neither athletic training nor detraining affects LV hypertrophy in adult, low-risk patients with HCM, file 6fed1fec-d42c-48cb-8456-f5b8c2ec3db2
|
2
|
|
Myocardial oedema contributes to interstitial expansion and associates with mechanical and electrocardiographic changes in takotsubo syndrome: a CMR T1 and T2 mapping study, file 87811389-d259-4c46-9d98-42461868a9e3
|
2
|
|
Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis, file 9ba7cb79-ddbb-435f-9cb5-57419fac6a8e
|
2
|
|
Relation of delayed intrinsicoid deflection of the QRS complex to sudden cardiac death in patients with hypertrophic cardiomyopathy, file c2df0fef-0732-4a50-b8fe-bb01f29cf73e
|
2
|
|
Electrocardiographic heterogeneity of patients with variant transthyretin amyloid cardiomyopathy: genotype-phenotype correlations, file cd4ecb26-b6df-4571-9f44-66e7b60eec72
|
2
|
|
Clinical Impact of Nonsustained Ventricular Tachycardia Recorded by the Implantable Cardioverter-Defibrillator in Patients with Hypertrophic Cardiomyopathy., file e3835313-0093-15e8-e053-a505fe0a3de9
|
2
|
|
Tp-Te interval predicts heart rate reduction after fingolimod administration in patients with multiple sclerosis, file e3835315-2205-15e8-e053-a505fe0a3de9
|
2
|
|
Heart failure progression in hypertrophic cardiomyopathy, Possible insights from cardiopulmonary exercise testing, file e3835315-9141-15e8-e053-a505fe0a3de9
|
2
|
|
RyR2 common gene variant G1886S and the risk of ventricular arrhythmias in ICD patients with heart failure., file e3835315-b900-15e8-e053-a505fe0a3de9
|
2
|
|
Outcomes of early invasive treatment strategy in elderly patients with non-ST elevation acute coronary syndromes, file e3835315-fa80-15e8-e053-a505fe0a3de9
|
2
|
|
Clinical management of patients with hypertension and high cardiovascular risk in specialised centers and in general practice. Analysis from an Italian Survey Questionnaire, file e383531b-aba3-15e8-e053-a505fe0a3de9
|
2
|
|
Admission heart rate and in-hospital course of patients with Takotsubo syndrome, file e383531b-c683-15e8-e053-a505fe0a3de9
|
2
|
|
Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy, file e3835327-7a4f-15e8-e053-a505fe0a3de9
|
2
|
|
Clinical outcomes in adult athletes with hypertrophic cardiomyopathy: a 7-year follow-up study, file e3835329-aa7a-15e8-e053-a505fe0a3de9
|
2
|
|
Response to letter from Madias regarding our article “Admission heart rate and in-hospital course of patients with Takotsubo syndrome”, file e383532b-cddc-15e8-e053-a505fe0a3de9
|
2
|
|
Real-world versus trial patients with transthyretin amyloid cardiomyopathy, file e383532c-188f-15e8-e053-a505fe0a3de9
|
2
|
|
Reply to the letter “Takotsubo syndrome: Any more covariates of its recurrence?”, file e383532d-3ba4-15e8-e053-a505fe0a3de9
|
2
|
|
A systematic review on focal takotsubo syndrome. a not-so-small matter, file f7b4e826-dd89-49e9-a737-75232cb28aff
|
2
|
|
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis, file 0cc740eb-17b3-4919-94d0-be4c75172f5d
|
1
|
|
Relation of delayed intrinsicoid deflection of the QRS complex to sudden cardiac death in patients with hypertrophic cardiomyopathy, file 199635fb-721f-4da3-a0d2-db368339c543
|
1
|
|
Prevalence and prognostic role of nonsustained ventricular tachycardia in cardiac amyloidosis, file 1c03c99f-d026-4bed-ad58-6ea07346c7b0
|
1
|
|
Clinical Course of Pregnancy and Long-Term Follow-Up After Delivery in Hypertrophic Cardiomyopathy, file 1f6a6c26-e1f5-4174-8071-0aa4e22dc0ca
|
1
|
|
The Many Faces of Arterial Hypertension in Hypertrophic Cardiomyopathy and Its Phenocopies: Bystander, Consequence, Modifier, file 2dae4ae2-8935-4f97-af2c-336f8b054c07
|
1
|
|
Prognostic implications of different clinical profiles in hypertrophic cardiomyopathy, file 2e2b5514-6be8-499f-85c2-785aa5b2d44a
|
1
|
|
A Plea for Smoking-Free Policies in COVID-19 Times: Cardiovascular Prevention as an Ally in Coronavirus Containment, file 35e44aad-8e41-4738-8d5a-53890565f0d2
|
1
|
|
Electrocardiographic changes in focal takotsubo syndrome. a case report, file 4119b4b4-4485-402e-9c91-e7c94d72a3a2
|
1
|
|
Real-world versus trial patients with transthyretin amyloid cardiomyopathy, file 491539de-db53-4ad3-8b93-9add9b58890d
|
1
|
| Totale |
2.007 |